AU2470101A - Genetic sequences associated with neural cell proliferation and disease - Google Patents

Genetic sequences associated with neural cell proliferation and disease

Info

Publication number
AU2470101A
AU2470101A AU24701/01A AU2470101A AU2470101A AU 2470101 A AU2470101 A AU 2470101A AU 24701/01 A AU24701/01 A AU 24701/01A AU 2470101 A AU2470101 A AU 2470101A AU 2470101 A AU2470101 A AU 2470101A
Authority
AU
Australia
Prior art keywords
disease
cell proliferation
neural cell
sequences associated
genetic sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24701/01A
Other languages
English (en)
Inventor
Yanxiang Cao
Monica Mody
Joe Z. Tsien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymetrix Inc
Princeton University
Original Assignee
Affymetrix Inc
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc, Princeton University filed Critical Affymetrix Inc
Publication of AU2470101A publication Critical patent/AU2470101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU24701/01A 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease Abandoned AU2470101A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16133799P 1999-10-25 1999-10-25
US60161337 1999-10-25
US22763900P 2000-08-24 2000-08-24
US60227639 2000-08-24
PCT/US2000/041515 WO2001030973A2 (en) 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease

Publications (1)

Publication Number Publication Date
AU2470101A true AU2470101A (en) 2001-05-08

Family

ID=26857750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24701/01A Abandoned AU2470101A (en) 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease

Country Status (4)

Country Link
EP (1) EP1226280A4 (de)
AU (1) AU2470101A (de)
CA (1) CA2389834A1 (de)
WO (1) WO2001030973A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003027276A2 (en) * 2001-09-24 2003-04-03 University Of Aarhus Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
CN101240021B (zh) * 2007-12-28 2010-09-08 天津医科大学附属肿瘤医院 抗人cdk5rap2蛋白的单克隆抗体及其应用
CA2740334C (en) 2010-05-14 2015-12-08 National Research Council Order-preserving clustering data analysis system and method
BR112016016153A2 (pt) 2014-01-13 2017-12-12 Berg Llc composições de enolase 1 (eno1) e usos das mesmas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination

Also Published As

Publication number Publication date
EP1226280A2 (de) 2002-07-31
EP1226280A4 (de) 2003-10-15
CA2389834A1 (en) 2001-05-03
WO2001030973A2 (en) 2001-05-03
WO2001030973A3 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU3869400A (en) Human cancer associated gene sequences and polypeptides
AU3997300A (en) Gene sequence variations with utility in determining the treatment of disease
AU6069300A (en) Novel human genes and gene expression products
AU3316600A (en) Gene expression in bladder tumors
AU1606897A (en) Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
AU1201600A (en) Controlling gene expression in living cells
AU3479700A (en) Genes associated with diseases of the colon
AU7476198A (en) Cell proliferation related genes
AUPQ262599A0 (en) Gene expression
AU2470101A (en) Genetic sequences associated with neural cell proliferation and disease
AU2153401A (en) Gene expression in biological conditions
AU2732000A (en) Reverse gene therapy
AU3457899A (en) Blk genes, gene products and uses thereof in apoptosis
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU5016200A (en) Diabetes gene
AU6773200A (en) Egfh2 genes and gene products
AU6578798A (en) Sugar-regulatory sequences in alpha-amylase genes
AU7064500A (en) Human narcolepsy gene
AU5052999A (en) Human ccr-2 gene polymorphisms
AU2001288940A1 (en) Gene and sequence variation associated with cancer
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU7500800A (en) Human fmo3 gene mutations and polymorphisms, and uses thereof
AU3099200A (en) Novel human wnt gene
AU2352301A (en) Gene expression in corneal diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase